14th Nov 2022 11:15
hVIVO PLC hVIVO hails growing contract values after winning £13.6mln RSV challenge trial deal 14.11.2022 / 12:14 CET/CEST The issuer is solely responsible for the content of this announcement. 14.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com |
| Language: | English |
| Company: | hVIVO PLC |
| United States | |
| ISIN: | GB00B9275X97 |
| EQS News ID: | 1486921 |
| End of News | EQS News Service |
1486921 14.11.2022 CET/CEST
corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.
Related Shares:
hVIVO